Invention Grant
- Patent Title: Selenium disulfide compositions for use in treating meibomian gland dysfunction
-
Application No.: US16093615Application Date: 2017-04-13
-
Publication No.: US11040062B2Publication Date: 2021-06-22
- Inventor: Doron Friedman , Yair Alster , Omer Rafaeli , Shimon Amselem , Zakhar Nudelman
- Applicant: Azura Ophthalmics Ltd.
- Applicant Address: IL Tel Aviv
- Assignee: Azura Ophthalmics Ltd.
- Current Assignee: Azura Ophthalmics Ltd.
- Current Assignee Address: IL Tel Aviv
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/IB2017/000542 WO 20170413
- International Announcement: WO2017/178892 WO 20171019
- Main IPC: A61K33/04
- IPC: A61K33/04 ; A61K9/00 ; A61K9/06 ; A61K9/16 ; A61K47/06 ; A61K47/44
Abstract:
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said methods are performed by administering said composition comprising a selenium disulfide and an anhydrous semi-solid base. The stable anhydrous composition are substantially free of selenium disulfide agglomerates.
Public/Granted literature
- US20200281966A1 Selenium Disulfide Compositions for Use in Treating Meibomian Gland Dysfunction Public/Granted day:2020-09-10
Information query
